Bg pattern

OTILONIO CINFA 40 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OTILONIO CINFA 40 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

otiloniocinfa 40 mg comprimidos recubiertos con película EFG

otilonio bromuro

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico,incluso si se trata de efec-tos adversos que no aparecen en este prospecto.Ver sección 4.

Contenido del prospecto

  1. Qué es otilonio cinfa y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar otilonio cinfa
  3. Cómo tomar otilonio cinfa
  4. Posibles efectos adversos
  5. Conservación de otilonio cinfa
  6. Contenido del envase e información adicional

1. Qué es otilonio cinfa y para qué se utiliza

otilonio cinfa contiene el principio activo otilonio bromuro, que pertenece a un grupo de medicamentos que actúan disminuyendo las contracciones intestinales.

otilonio se utiliza para el tratamiento de los espasmos y alteraciones de la motilidad gastrointestinal en adultos.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar otilonio cinfa

No tome otilonio cinfa

  • si es alérgico al otilonio bromuro o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).
  • si padece de obstrucción intestinal.

Advertencias y precauciones

Consulte a su médico o farmacéutico antes de empezar a tomar otilonio cinfa si:

  • Está tomando varios medicamentos y/o es un paciente de edad avanzada
  • tiene glaucoma (aumento de la presión en el ojo)
  • tiene hipertrofia de próstata (agrandamiento de la próstata)
  • tiene estenosis pilórica (dificultad en el paso del contenido del estómago al intestino)
  • tiene problemas de hígado o de riñón
  • tiene problemas de corazón como taquicardia (aumento del ritmo cardiaco)
  • tiene hipertiroidismo (alteración de la glándula tiroides con aumento de hormonas tiroideas)
  • tiene colitis ulcerosa (enfermedad inflamatoria del intestino)
  • tiene reflujo esofágico (paso del contenido del estómago al esófago).

Niños

No utilizar este medicamento en niños y adolescentes.

Ancianos

Los pacientes de edad avanzada deben tomar este medicamento con precaución.

Otros medicamentos y otilonio cinfa

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento.

Embarazo y lactancia

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

La seguridad de uso de otilonio durante el embarazo y la lactancia no ha sido aún establecida.

Conducción y uso de máquinas

otilonio no interfiere sobre la capacidad de conducir vehículos o utilizar máquinas.

otilonio cinfa contiene sodio

Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.

3. Cómo tomar otilonio cinfa

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico o farmacéutico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

La dosis recomendada es de 1 comprimido de otilonio (40 mg de bromuro de otilonio) dos o tres veces al día, según criterio médico.

Forma de administración:

Los comprimidos se administran por vía oral.

Los comprimidos deben tomarse, aproximadamente 20 minutos antes de las comidas con medio vaso de agua.

La duración máxima del tratamiento es de 4 semanas.

En caso de reaparición de la sintomatología dolorosa, el médico deberá evaluar la conveniencia de instaurar un nuevo tratamiento.

Si toma más otilonio cinfa delque debe

En caso de sobredosis o ingestión accidental, acudir inmediatamente a su médico o farmacéutico o llame al Servicio de Información Toxicológica, teléfono: 915 62 04 20, indicando el medicamento y la cantidad ingerida.

Si olvidó tomarotilonio cinfa

No tome una dosis doble para compensar las dosis olvidadas.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Efectos adversos de frecuencia no conocida (no puede estimarse a partir de los datos disponibles):

  • dolor de cabeza
  • nauseas, vómitos, dolor en el estómago,
  • urticaria
  • vértigos
  • fatiga

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directa-mente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: www.notificaRAM.es . Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Otilonio cinfa

Mantener este medicamento fuera de la vista y del alcance de los niños.

Este medicamento no requiere condiciones especiales de conservación.

No utilice este medicamento después de la fecha de caducidad que aparece el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el Punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición deotilonio cinfa

  • El principio activo es otilonio bromuro. Cada comprimido contiene 40 mg de otilonio bromuro.
  • Los demás componentes son: celulosa microcristalina, almidón pregelatinizado (de maíz), carboximetilalmidón sódico (tipo A) (de patata), glicerol diesterato, y dimeticona.
  • El recubrimiento es: hipromelosa, macrogol 6000, dióxido de titanio (E-171) y talco.

Aspecto del producto y contenido del envase

otilonio cinfa se presenta en forma de comprimidos recubiertos con película. Los comprimidos son redondos y de color blanco.

Se presenta en blísteres de PVC/aluminio que contienen 60 comprimidos recubiertos con película.

Titular de la autorización de comercialización y responsable de la fabricación

Titular de la autorización de comercialización:

Laboratorios Cinfa, S.A

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) – España

Responsable de la fabricación:

Neuraxpharm Pharmaceuticals S.L

Avda. Barcelona, 69

08970, Sant Joan Despí (Barcelona)

España

o

Laboratorios Cinfa, S.A

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) – España

Fecha de la última revisión de este prospecto:noviembre 2021

La información detallada de este medicamento está disponible en la página web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.es/

Puede acceder a información detallada y actualizada sobre este medicamento escaneando con su teléfono móvil (smartphone) el código QR incluido en el prospecto y cartonaje. También puede acceder a esta información en la siguiente dirección de internet: https://cima.aemps.es/cima/dochtml/p/79384/P_79384.html

Código QR a: https://cima.aemps.es/cima/dochtml/p/79384/P_79384.html

Online doctors for OTILONIO CINFA 40 mg FILM-COATED TABLETS

Discuss questions about OTILONIO CINFA 40 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for OTILONIO CINFA 40 mg FILM-COATED TABLETS?
OTILONIO CINFA 40 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in OTILONIO CINFA 40 mg FILM-COATED TABLETS?
The active ingredient in OTILONIO CINFA 40 mg FILM-COATED TABLETS is otilonium bromide. This information helps identify medicines with the same composition but different brand names.
How much does OTILONIO CINFA 40 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for OTILONIO CINFA 40 mg FILM-COATED TABLETS is around 11.02 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures OTILONIO CINFA 40 mg FILM-COATED TABLETS?
OTILONIO CINFA 40 mg FILM-COATED TABLETS is manufactured by Laboratorios Cinfa S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of OTILONIO CINFA 40 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OTILONIO CINFA 40 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to OTILONIO CINFA 40 mg FILM-COATED TABLETS?
Other medicines with the same active substance (otilonium bromide) include OTILONIO QUALIGEN 40 mg FILM-COATED TABLETS, SPASMOCTYL 40, SPASMOCTYL PEDIATRIC. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media